Neuroprotective effects of chronic hesperetin administration in mice (original) (raw)

References

• Adams, J. D. Jr., Klaidman, L. K., Odunze, I. N., Shen, H. C., and Miller, C. A., Alzheimer’s and Parkinson’s disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol. Chem. Neuropathol., 14, 213–226 (1991).
  Article PubMed CAS Google Scholar
• Aebi, H., Catalase in vitro. Methods Enzymol., 105, 121–126 (1984).
  Article PubMed CAS Google Scholar
• Aldini, G., Dalle-Donne, I., Facino, R. M., Milzani, A., and Carini, M., Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med. Res. Rev., 27, 817–868 (2007).
  Article PubMed CAS Google Scholar
• Ansari, M. A., Joshi, G., Huang, Q., Opii, W. O., Abdul, H. M., Sultana, R., and Butterfield, D. A., In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer’s disease and other oxidative stress-related neurodegenerative disorders. Free Radic. Biol. Med., 41, 1694–1703 (2006).
  Article PubMed CAS Google Scholar
• Bharath, S., Hsu, M., Kaur, D., Rajagopalan, S., and Andersen, J. K., Glutathione, iron and Parkinson’s disease. Biochem. Pharmacol., 64, 1037–1048 (2002).
  Article PubMed CAS Google Scholar
• Bonilla, E., Huntington disease. Invest. Clin., 41, 117–141 (2000).
  PubMed CAS Google Scholar
• Carlberg, I. and Mannervik, B., Glutathione reductase. Methods Enzymol., 113, 484–490 (1985).
  Article PubMed CAS Google Scholar
• Cho, J., Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin. Arch. Pharm. Res., 29, 699–706 (2006).
  Article PubMed CAS Google Scholar
• Choi, E. J., Kim, G. D., Chee, K. M., and Kim, G. H., Effects of hesperetin on vessel structure formation in mouse embryonic stem (mES) cells. Nutrition, 22, 947–951 (2006).
  Article PubMed CAS Google Scholar
• Choi, E. J., Antioxidative effects of hesperetin against 7,12-dimethylbenz(a)anthracene-induced oxidative stress in mice. Life Sci., 82, 1059–1064 (2008).
  Article PubMed CAS Google Scholar
• Cooper, A. J. L., Glutathione in the brain: disorders of glutathione metabolism: The Molecular and Genetic Basis of Neurological Disease. Butterworth-Heinemann, Boston, 1997, pp. 1195–1230, (1997).
  Google Scholar
• Cruz-Aguado, R., Turner, L. F., Diaz, C. M., and Pinero, J., Nerve growth factor and striatal glutathione metabolism in a rat model of Huntington’s disease. Restor. Neurol. Neurosci., 17, 217–221 (2000).
  PubMed CAS Google Scholar
• Erdem, E., Carlier, R., Idir, A. B., Masnou, P. O., Moulonguet, A., Adams, D., and Doyon, D., Gadolinium-enhanced MRI in central nervous system Behçet’s disease. Neuroradiology, 35, 142–144 (1993).
  Article PubMed CAS Google Scholar
• Flohé, L. and Günzler, W. A., Assays of glutathione peroxidase. Methods Enzymol., 105, 114–121 (1984).
  Article PubMed Google Scholar
• Fridovich, I., Superoxide anion radical (O2−.), superoxide dismutases, and related matters. J. Biol. Chem., 272, 18515–18517 (1997).
  Article PubMed CAS Google Scholar
• Fridovich, I., Superoxide radical and superoxide dismutases. Annu. Rev. Biochem., 64, 97–112 (1995).
  Article PubMed CAS Google Scholar
• Garg, A., Garg, S., Zaneveld, L. J., and Singla, A. K., Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother. Res., 15, 655–669 (2001).
  Article PubMed CAS Google Scholar
• Hirrlinger, J., Schulz, J. B., and Dringen, R., Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson’s disease. J. Neurochem., 82, 458–467 (2002).
  Article PubMed CAS Google Scholar
• Hissin, P. J. and Hilf, R., A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem., 74, 214–226 (1976).
  Article PubMed CAS Google Scholar
• Ho, Y. S., Magnenat, J. L., Bronson, R. T., Cao, J., Gargano, M., Sugawara, M., and Funk, C. D., Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J. Biol. Chem., 272, 16644–16651 (1997a).
  Article PubMed CAS Google Scholar
• Ho, Y. S., Swenson, L., Derewenda, U., Serre, L., Wei, Y., Dauter, Z., Hattori, M., Adachi, T., Aoki, J., Arai, H., Inoue, K., and Derewenda, Z. S., Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer. Nature, 385, 89–93 (1997b).
  Article PubMed CAS Google Scholar
• Hwang, S. L. and Yen, G. C., Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells. J. Agric. Food Chem., 859–864 (2008).
• Jaeger, A., Wälti, M., and Neftel, K., Side effects of flavonoids in medical practice. Prog. Clin. Biol. Res., 280, 379–394 (1988).
  PubMed CAS Google Scholar
• Kim, J. Y., Jung, K. J., Choi, J. S., and Chung, H. Y., Hesperetin: a potent antioxidant against peroxynitrite. Free Radic. Res., 38, 761–769 (2004).
  Article PubMed CAS Google Scholar
• Marklund, S. and Marklund, G., Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem., 47, 469–474 (1974).
  Article PubMed CAS Google Scholar
• Moreira, P. I., Siedlak, S. L., Aliev, G., Zhu, X., Cash, A. D., Smith, M. A., and Perry, G., Oxidative stress mechanisms and potential therapeutics in Alzheimer disease. J. Neural Transm., 112, 921–932 (2005).
  Article PubMed CAS Google Scholar
• Nunomura, A., Moreira, P. I., Lee, H. G., Zhu, X., Castellani, R. J., Smith, M. A., and Perry, G., Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol. Disord. Drug Targets, 6, 411–423 (2007).
  Article PubMed CAS Google Scholar
• Ohkawa, H., Ohishi, N., and Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95, 351–358 (1979).
  Article PubMed CAS Google Scholar
• Pollard, S. E., Whiteman, M., and Spencer, J. P., Modulation of peroxynitrite-induced fibroblast injury by hesperetin: a role for intracellular scavenging and modulation of ERK signaling. Biochem. Biophys. Res. Commun., 347, 916–923 (2006).
  Article PubMed CAS Google Scholar
• Rao, A. V. and Balachandran, B., Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr. Neurosci., 5, 291–309 (2002).
  Article PubMed CAS Google Scholar
• Reznick, A. Z. and Packer, L., Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol., 233, 357–363 (1994).
  Article PubMed CAS Google Scholar
• Ross, J. A. and Kasum, C. M., Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr., 22, 19–34 (2002).
  Article PubMed CAS Google Scholar
• Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P., and Marsden, C. D., Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol., 36, 348–355 (1994).
  Article PubMed CAS Google Scholar
• Suk, K., Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases. A focus on traditional medicines and flavonoids. Neurosignals., 14, 23–33 (2005).
  Article PubMed CAS Google Scholar
• Zhu, Y., Carvey, P. M., and Ling, Z., Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res., 1090, 35–44 (2006).
  Article PubMed CAS Google Scholar

Download references